GSK in the news as UK pharma giant eyes more UK investment after pharma deals—Emma Walmsley-led firm persists in global drug growth.
The number of meningitis cases linked to an outbreak in Kent has risen to 27, prompting expanded vaccination efforts. Authorities are investigating transmission, with increased demand for vaccines causing shortages. Public health officials emphasize the low risk to the wider population but urge vigilance.
GSK has struck a multi-billion deal to acquire Nuvalent, adding three late-stage cancer drugs to its portfolio, including two lung-cancer therapies under FDA review. The acquisition aims to boost sales growth, expand the lung-cancer platform, and position GSK for a potential rise in annual revenue by 2031.